a public good project by the
Synthesis
Company
of California

© 2026

M. Hamidou | doi.page

0 works0 citations0 h-index

M. Hamidou

Nantes Université(FR)

Publications by Year

Research Areas

Vasculitis and related conditions, Systemic Lupus Erythematosus Research, Sarcoidosis and Beryllium Toxicity Research, Renal Diseases and Glomerulopathies, Chronic Lymphocytic Leukemia Research

Most-Cited Works

→ Rituximab versus Azathioprine for Maintenance in ANCA-Associated Vasculitis(2014)1,057 cited
→ Eosinophilic granulomatosis with polyangiitis (Churg‐Strauss): Clinical characteristics and long‐term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort(2012)899 cited
→ Azathioprine or Methotrexate Maintenance for ANCA-Associated Vasculitis(2008)659 cited
→ Predictive Features of Severe Acquired ADAMTS13 Deficiency in Idiopathic Thrombotic Microangiopathies: The French TMA Reference Center Experience(2010)412 cited
→ CNS involvement and treatment with interferon-α are independent prognostic factors in Erdheim-Chester disease: a multicenter survival analysis of 53 patients(2011)380 cited
→ Clinical similarities and differences of patients with X-linked lymphoproliferative syndrome type 1 (XLP-1/SAP deficiency) versus type 2 (XLP-2/XIAP deficiency)(2010)364 cited

→ Comparison of individually tailored versus fixed-schedule rituximab regimen to maintain ANCA-associated vasculitis remission: results of a multicentre, randomised controlled, phase III trial (MAINRITSAN2)(2018)327 cited

→ Vasculitides associated with malignancies: Analysis of sixty patients(2007)295 cited

→ Hierarchical cluster and survival analyses of antisynthetase syndrome: Phenotype and outcome are correlated with anti-tRNA synthetase antibody specificity(2012)294 cited

→ Efficacy and safety of first-line rituximab in severe, acquired thrombotic thrombocytopenic purpura with a suboptimal response to plasma exchange. Experience of the French Thrombotic Microangiopathies Reference Center(2011)287 cited